Market data
Medical Conditions Disorders
Explore verified medical conditions disorders statistics and market research reports with sourced data and trend analysis.
Latest update:
Elif Demirci
Diabetes Mellitus Statistics
Frequent polyuria affects 80% of undiagnosed type 2 diabetes cases—see the hidden burden, key costs, and risk factors next.
Glioblastoma Survival Statistics
In patients over 75, median glioblastoma survival is only 3–4 months even with treatment—see why outcomes differ across ages and therapies.
Color Blind Statistics
Red-green gene mutations drive 99.9% of color blindness—see how OPN1LW/OPN1MW changes affect vision and what tests reveal.
Insomnia Statistics
Diagnosing insomnia with polysomnography is confirmed in only 20–30%—see what objective tests can (and can’t) prove.
Scoliosis Statistics
Bracing reduces progression to surgical-range curves in adolescent idiopathic scoliosis by about 70%—learn who benefits and what to expect.
Pku Statistics
From 99.7 percent sensitivity and a false positive rate under 0.05 percent to confirmatory classic PKU requiring plasma Phe above 20 mg/dL, this PKU statistics page connects screening thresholds and genetic testing accuracy in one place. It also pulls the real-world stakes into view, from Turkey’s high incidence of 1 in 2,605 births to the 95 percent chance of preventing brain damage when diet starts within 7 to 10 days, showing exactly why timing and testing choices matter.
Diabetic Foot Ulcer Statistics
At diagnosis, Wagner grade 3+ ulcers appear in 25% of people while the mean ulcer is already 2.5 cm² and infection is present in 50 to 60% of diabetic foot ulcers, a combination that helps explain why osteomyelitis shows up in 20% of chronic cases. This page connects those early warning signals to outcomes like 14 to 24% leading to amputation and a 30-day readmission rate of 30%, so clinicians can spot risk sooner and act faster.
Eye Cancer Statistics
Uveal melanoma hits hardest after 60, yet blue or fair features, BAP1 germline mutations, and certain occupations can swing lifetime risk dramatically, from 50 cases per million ages 60 to 70 to 1 in 14,000 for whites overall. Want the bigger picture of risk, diagnosis, and outcomes across the eye. Expect eye cancers to look wildly different by age, genetics, and immune status, with key survival contrasts and rare but high stakes syndromes like xeroderma pigmentosum and RB1 related retinoblastoma.
Prostate Cancer Survival Statistics
From 2014–2020 SEER data to major trial results, this Prostate Cancer Survival statistics page spotlights how dramatically outcomes separate by stage and treatment, including metastatic hormone sensitive prostate cancer median overall survival of 57.4 months with the LATITUDE regimen versus 44.0 months with control and 19.2 months with olaparib versus 14.7 months with placebo in PROfound. You will also see why markers like PSA, lymph nodes, and Gleason 8 to 10 matter for survival, alongside a global snapshot of about 375,000 prostate cancer deaths in 2020.
Breast Cancer Awareness Month Statistics
Breast Cancer Awareness Month is a reminder that progress is real but uneven: 34% of women’s new cancer diagnoses are breast cancer, yet only 27% of eligible women actually receive screening mammography. Get the sharp contrast and the potential upside behind these 2024, 2021, and meta analysis figures, from a 10% jump in screening coverage linked to fewer deaths to how targeted education can raise mammography intentions.
Pelvic Inflammatory Disease Statistics
Nearly all PID starts with ascent from the lower genital tract and in systematic reviews 78% of cases are linked to chlamydia or gonorrhea and or BV associated polymicrobial infection, yet 17% of women with PID go on to chronic pelvic pain. This statistics page connects preventable triggers such as a 2.0 fold higher risk in current smokers and the 50% of untreated chlamydia that resolve spontaneously with the downstream consequences like tubal factor infertility, ectopic pregnancy, and rare but serious tubo ovarian abscess.
Down Syndrome Life Expectancy Statistics
Adults with Down syndrome are living longer and Sweden saw mortality fall about 40% from 1980 to 2010, yet conditions like Alzheimer type pathology affecting up to 90% by age 40 to 60, congenital heart disease at about 40%, and hearing and sleep disordered breathing in roughly half or more still shape daily health and long term outcomes. This page brings together UK and Netherlands life expectancy figures, prevalence and risk estimates, and care and cost snapshots like outpatient spending at 38% so you can see what has improved, what has not, and where modern care makes the biggest difference.
Hemorrhoid Statistics
Hemorrhoids are present in about 4.4% of the global population at any given time, yet the clinic picture is far more common with 40% of people seen for proctology consultations reporting hemorrhoids. You will also get practical dose level and timing facts such as 10 to 15 minute sitz bath sessions and 1 day median recovery after rubber band ligation, plus how office based options can help quickly while recurrence stays generally under 5% after hemorrhoidectomy.
Bird Flu Statistics
With global poultry trade and prices still moving, HPAI is estimated to have triggered tens of billions of dollars in worldwide production and control costs and can knock poultry supply off course even as the global poultry meat market sits around $360 billion in 2023. This page connects how mammal and human receptor findings from H5N1 research translate into practical controls, from biosecurity and movement restrictions to vaccination and 10 day symptom monitoring guidance, so you can see why the next outbreak may depend as much on farm practice as on viral mutations.
Autism Prevalence Statistics
Autism prevalence is estimated at about 1 in 34 children in the US in 2014 and roughly 2.64% in South Korea in 2018, alongside a pooled global figure near 1 in 86, so the same condition looks strikingly different depending on where and how it is measured. This page also ties prevalence to what comes next, including typical diagnosis timing around age 4 and high comorbidity levels like ADHD symptoms, sleep problems, and epilepsy, plus the real-world cost pressures on families and services.
Liver Cancer Statistics
Liver cancer now accounts for 3.6% of all cancer deaths among women globally in 2020, yet the US SEER data show 53.0% of patients are diagnosed at distant stage, creating a stark gap between opportunity and outcomes. This page pulls together prevention and detection evidence from HBV and HCV natural history to HCC surveillance and treatment trial results, including a 27% objective response with atezolizumab plus bevacizumab in IMbrave150.
Breast Cancer Research Statistics
From a distant stage 5-year relative survival of about 30% in the United States to the stark reality that 31% of US diagnoses arrive at distant stage, these statistics connect outcomes to what is happening at diagnosis while also tracking worldwide burden and research momentum. You will also see how modern treatment advances and targeted therapies reshaped key trial outcomes and survival estimates, alongside the funding scale behind them, including NIH awarding $2.0 billion in breast cancer related support in 2022.
Hypertension Statistics
Despite about 76% average adherence and modern strategies that can drop systolic BP by around 5 mmHg, only 36.9% of adults with hypertension are controlled globally, leaving roughly one quarter of adults with raised BP and older adults often carrying the heaviest share of prevalence. This page maps what is driving poor control, from medication interruptions and follow up gaps to home and remote monitoring results, and shows how tighter BP lowering and combination regimens translate into fewer strokes and heart failure.
Maternal Death Statistics
Maternal death risk is not just about distance to hospitals it is about whether care is skilled, timely, and affordable, with unsafe abortion still linked to an estimated 7 to 8 percent of maternal deaths globally and over half around 55 percent occurring where women lack skilled support at delivery. Even as the global maternal mortality ratio fell by about 34 percent since 2000, the gaps remain stark, including 2020 evidence that 52 percent of deaths were potentially avoidable with timely quality obstetric care and that emergency obstetric readiness is limited by referral and transport failures.
Global Hiv Statistics
With 2023 still showing how fast the HIV response is moving, the global HIV treatment market sits at $41.4 billion and new prevention options cut infections dramatically, from a 96 percent transmission drop with ART in HPTN 052 to cabotegravir PrEP reducing incidence to 0.24 percent per year in HPTN 083. This Global Hiv snapshot sets those breakthroughs against retention and durability metrics so you can see not just what works in trials, but what lasts in real programs.